New Nanodevice Delivers Hydrogen to Fight Cancer and Boost Immunity
Modulating the Electronic Structure of MnNi <sub>2</sub> S <sub>3</sub> Nanoelectrodes to Activate Pyroptosis for Electrocatalytic Hydrogen‐Immunotherapy
Research hubs: Immune System
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Jingrui Li, Gang Wang, Zhaoyu Wen, Shumin Sun, Zhihui Han, Yuqi Yang, Jie Wu, Zifan Pei, Luyao Liu, Youdong Chen, Liang Cheng
- Journal
- Advanced Materials
- Year
- 2024
- DOI
- 10.1002/adma.202412925
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
This research was done on cells or tissue in a lab, not in people or animals.
TL;DR
Scientists have developed a new method using manganese-doped nanoelectrodes to improve the delivery and effectiveness of hydrogen therapy for treating tumors by activating the body's immune response.
Key Finding
Manganese-doped nickel sulfide nanoelectrodes successfully generated and delivered hydrogen gas in a controlled, voltage-dependent manner, inducing tumor cell death through pyroptosis while simultaneously enhancing anti-tumor immune responses in cell culture experiments.
Summary
Researchers designed special nanoelectrodes (tiny electrodes made from manganese and nickel compounds) that can generate hydrogen gas through electrolysis (splitting water using electrical current) and deliver it directly to tumor cells in laboratory cultures. The hydrogen triggered tumor cells to die through a process called pyroptosis (a type of cell death) and also boosted immune cells called CD8+ T lymphocytes to attack the tumors more effectively.
Practical Takeaway
This is early-stage laboratory research in cell cultures only—not yet tested in animals or humans. While the results suggest a novel approach to combining hydrogen delivery with immune activation for cancer therapy, significant development would be needed before any clinical application. The voltage-dependent delivery system is a theoretical advantage over passive hydrogen water consumption, but real-world effectiveness and safety remain unknown.
Abstract (excerpt)
Abstract Hydrogen (H 2 ) therapy has demonstrated antitumor effect, but the therapeutic efficacy is restricted by the low solubility and nontarget delivery of H 2 . Electrolysis of H 2 O by electrocatalysts sustainably releases enormous amounts of H 2 and inspires the precise delivery of H 2…